Fate Therapeutics, Inc. (NASDAQ: FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a ...

Explore the outstanding achievements of the National Academy of Medicine (NAM) Class of 2025, including groundbreaking ...

It is not unusual for advanced prostate cancer to become resistant to treatment. Of these resistant cases, some progress to a ...

A new study in fruit flies describes how an animal’s gut reacts differently to beneficial microbes versus harmful pathogens. A pathway known for repairing damaged genetic material, called the ...

At the University of Illinois, we’ve discovered that faith and science, united through dialogue and understanding, is our ...

Explore how proteomics in drug discovery supports drug target identification, biomarker discovery and the unearthing of safer ...

India’s CRDMO sector, currently valued at $3–3.5 billion, accounts for just 2–3% of the $140–145 billion global market. But ...

Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.

The American College of Medical Genetics and Genomics (ACMG) announced today that its Board of Directors has approved the establishment of a Newborn Screening Coalition, reaffirming ACMG’s commitment ...

New research backs up previous findings about a connection between the two, though some have urged caution in interpreting ...

A new multimodal AI model integrates pathology, genomics, and clinical data to improve pan-cancer prognosis prediction, offering enhanced generalizability and efficiency across cancer types.